|
Volumn 19, Issue 3, 2001, Pages 249-254
|
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer
a b a a c d e a |
Author keywords
Bryostatin 1; Head and neck cancer; Hyponatremia; Myalgia; Sarcoma; Toxicities
|
Indexed keywords
BRYOSTATIN 1;
PROTEIN KINASE C;
ADULT;
ADVANCED CANCER;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG ACTIVITY;
FEMALE;
HEAD AND NECK CANCER;
HUMAN;
HUMAN TISSUE;
HYPONATREMIA;
MALE;
MYALGIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOFT TISSUE SARCOMA;
TREATMENT OUTCOME;
|
EID: 0034851020
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1010628903248 Document Type: Article |
Times cited : (30)
|
References (20)
|